Evidence in focus: POLAR3 Total Hip Solution delivers excellent performance with high survivorship at 10 years

AUTHOR(S): Global Clinical & Medical Affairs, S+N

POLARSTEM and R3 with OXINIUM showed significant reduction in revision rate, when compared with class average (p=0.01)

5 abril 2022